Mar. 28, 2026
Oracle Investors Seek Lead Plaintiff in Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP files lawsuit alleging Oracle misled investors about AI infrastructure costs
Mar. 27, 2026
Shareholders Urged to Join Class Action Lawsuit Against ImmunityBio
Robbins LLP Reminds Investors of Allegations of Misleading Claims About Lead Product Anktiva
Mar. 27, 2026
Robbins LLP Informs Investors of ImmunityBio Class Action Lawsuit
Law firm notifies investors of pending lawsuit against biotech company ImmunityBio.
Mar. 24, 2026
Congress Asset Management Co. Cuts Stake in Halozyme Therapeutics
Biopharmaceutical company Halozyme Therapeutics sees 9.4% decrease in shares held by investment firm
Mar. 23, 2026
Driven Brands Investors Seek Lead Plaintiff Role in Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces opportunity for Driven Brands shareholders to lead class action over accounting errors
Mar. 23, 2026
Camping World Investors Seek Lead Plaintiff Role in Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces opportunity for Camping World investors to lead class action lawsuit over alleged securities fraud.
Mar. 23, 2026
Innovus Pharmaceuticals Outperforms Antibe Therapeutics in Revenue and Earnings
Innovus Pharmaceuticals shows stronger financial metrics and institutional ownership compared to Antibe Therapeutics.
Mar. 22, 2026
Boston Scientific Investors Seek Lead Plaintiff Role in Class Action Lawsuit
Investors with substantial losses have until May 4, 2026 to seek appointment as lead plaintiff in the case against Boston Scientific Corporation.
Mar. 21, 2026
Qualcomm Stockholders Back Board, Equity Plan; CEO Amon Highlights AI, Robotics and Data Center Push
Qualcomm's annual meeting saw stockholder approval of board nominees, auditor ratification, and executive compensation, as CEO Cristiano Amon outlined the company's diversification strategy.
Mar. 21, 2026
Investors Seek Lead Plaintiff Role in monday.com Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces opportunity for investors with substantial losses to lead case against monday.com.
Mar. 21, 2026
Investors Seek Lead Plaintiff Role in monday.com Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces opportunity for monday.com investors with substantial losses
Mar. 21, 2026
Investors with Substantial Losses Have Opportunity to Lead monday.com Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces class action lawsuit against monday.com Ltd. and its executives
Mar. 21, 2026
Neurocrine Biosciences Outlines 2026 Execution, 2027 Data Milestones
Biotech firm expects Ingrezza revenue of $2.7B-$2.8B in 2026, with pricing pressure from Inflation Reduction Act
Mar. 20, 2026
XPENG Reports Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
The Company achieved a positive net profit of RMB0.38 billion in the fourth quarter of 2025, recorded a positive net profit for a single quarter for the first time.
Mar. 19, 2026
RYVYL Inc. Postpones Shareholder Vote on Roundtable Merger
Company needs additional votes to confirm proposed acquisition of Web 3 media platform
Mar. 19, 2026
Driven Brands Investors Seek Lead Plaintiff Role in Class Action Lawsuit
Lawsuit alleges accounting errors in Driven Brands' financial statements from 2023-2025
Mar. 19, 2026
Investors Seek Lead Plaintiff Role in Trip.com Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces opportunity for Trip.com investors to lead class action over alleged regulatory risks.
Mar. 19, 2026
RYVYL Shareholders Overwhelmingly Approve Merger with Roundtable
Company adjourns special meeting to allow more votes to be cast before final approval
Mar. 19, 2026
RYVYL Inc. Postpones Shareholder Meeting for Proposed Merger
Approximately 99% of votes cast so far are in favor of the merger with Roundtable.
Mar. 19, 2026
Investors Seek Lead Plaintiff Role in Trip.com Antitrust Lawsuit
Robbins Geller Rudman & Dowd LLP announces opportunity for Trip.com investors to lead class action lawsuit
